This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://localhost/temp/predkladatel/
n7http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n8http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n16http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61988987%3A17110%2F02%3AA1000VRZ%21RIV10-MSM-17110___/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n5http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61988987%3A17110%2F02%3AA1000VRZ%21RIV10-MSM-17110___
rdf:type
n8:Vysledek skos:Concept
dcterms:description
Backgrounds: The current renaissance of the interest in prognostic factors (PF) in multiple myeloma (MM) is determined by the extended possibilities of intensive treatment regimes, which require individual stratification of patients with a need of independent highly predictive prognostic factors. Design and Subjects: The prognostic significance of 7 selected staging systems and some cytokines and adhesive molecules was evaluated in the group of 237 patients with MM treated between 1991-2002 by conventional therapy. Backgrounds: The current renaissance of the interest in prognostic factors (PF) in multiple myeloma (MM) is determined by the extended possibilities of intensive treatment regimes, which require individual stratification of patients with a need of independent highly predictive prognostic factors. Design and Subjects: The prognostic significance of 7 selected staging systems and some cytokines and adhesive molecules was evaluated in the group of 237 patients with MM treated between 1991-2002 by conventional therapy.
dcterms:title
Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers
skos:prefLabel
Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers
skos:notation
RIV/61988987:17110/02:A1000VRZ!RIV10-MSM-17110___
n3:aktivita
n12:S
n3:aktivity
S
n3:cisloPeriodika
15
n3:dodaniDat
n5:2010
n3:domaciTvurceVysledku
n7:3867781 n7:1383914
n3:druhVysledku
n11:J
n3:duvernostUdaju
n15:S
n3:entitaPredkladatele
n16:predkladatel
n3:idSjednocenehoVysledku
660625
n3:idVysledku
RIV/61988987:17110/02:A1000VRZ
n3:jazykVysledku
n9:eng
n3:klicovaSlova
Cytokines-cytoadhesive molecules; Multiple myeloma; Prognostic factors; Propidium-iodide proliferative index of plasmocytes; Thymidinkinase
n3:klicoveSlovo
n4:Thymidinkinase n4:Multiple%20myeloma n4:Prognostic%20factors n4:Cytokines-cytoadhesive%20molecules n4:Propidium-iodide%20proliferative%20index%20of%20plasmocytes
n3:kodStatuVydavatele
CZ - Česká republika
n3:kontrolniKodProRIV
[10C6676559FD]
n3:nazevZdroje
Klinická onkologie
n3:obor
n17:FE
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n5:2002
n3:svazekPeriodika
suppl.
n3:tvurceVysledku
Gumulec, Jaromír Martínek, Arnošt
s:issn
0862-495X
s:numberOfPages
8
n13:organizacniJednotka
17110